Review: taking Benzonatate and Mucinex together


Summary

Drug interactions are reported among people who take Benzonatate and Mucinex together. This review analyzes the effectiveness and drug interactions between Benzonatate and Mucinex. It is created by eHealthMe based on reports of 294 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Benzonatate and Mucinex >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Benzonatate

Benzonatate has active ingredients of benzonatate. It is often used in cough. (latest outcomes from Benzonatate 1,938 users)

Mucinex

Mucinex has active ingredients of guaifenesin. It is often used in cough. (latest outcomes from Mucinex 5,967 users)

On Jul, 28, 2016

294 people who take Benzonatate, Mucinex are studied.


Number of reports submitted per year:

Benzonatate and Mucinex drug interactions.

Drug effectiveness over time:

Benzonatate:
  • < 1 month: 4.0% - (1 of 21 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Mucinex:
  • < 1 month: 15.0% - (3 of 19 people)
  • 1 - 6 months: 0.0% - (0 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Benzonatate:
  • female: 10.0% - (2 of 20 people)
  • male: 0.0% - (0 of 4 people)
Mucinex:
  • female: 15.0% - (3 of 20 people)
  • male: 0.0% - (0 of 4 people)

Drug effectiveness by age:

Benzonatate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 0.0% - (0 of 6 people)
  • 30-39: 40.0% - (2 of 5 people)
  • 40-49: 0.0% - (0 of 4 people)
  • 50-59: 0.0% - (0 of 4 people)
  • 60+: 0.0% - (0 of 4 people)
Mucinex:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 16.0% - (1 of 6 people)
  • 30-39: 20.0% - (1 of 5 people)
  • 40-49: 0.0% - (0 of 4 people)
  • 50-59: 25.0% - (1 of 4 people)
  • 60+: 0.0% - (0 of 4 people)

Most common drug interactions over time *:

< 1 month:
  • abdominal pain upper
  • arthralgia
  • blood pressure increased
  • chest discomfort
  • chest pain
  • cough
  • dehydration
  • hyponatraemia
  • nausea
  • pain in extremity
1 - 6 months:
  • dizziness
  • drug hypersensitivity
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • fever
  • nausea
  • slurred speech
  • swelling
6 - 12 months:
  • haematocrit decreased
  • haemoglobin decreased
  • interstitial lung disease
  • lymphocyte count decreased
  • mean cell volume increased
  • monocyte count decreased
  • tiredness
  • bronchitis
  • chronic obstructive pulmonary disease
  • glomerular filtration rate decreased
1 - 2 years:
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • diabetic nephropathy
  • glucose tolerance impaired
  • hypoglycaemia
  • type 2 diabetes mellitus
not specified:
  • dyspnoea
  • pain
  • anxiety
  • pneumonia
  • chest pain
  • back pain
  • pain in extremity
  • cough
  • anaemia
  • chronic obstructive pulmonary disease

Most common drug interactions by gender *:

female:
  • pain
  • diarrhoea
  • anxiety
  • cough
  • dyspnoea
  • oedema peripheral
  • depression
  • chest pain
  • nausea
  • injury
male:
  • dyspnoea
  • pneumonia
  • arthralgia
  • chest pain
  • pain in extremity
  • chronic obstructive pulmonary disease
  • asthenia
  • back pain
  • musculoskeletal pain
  • pain

Most common drug interactions by age *:

0-1:
  • orthostatic hypotension
10-19:
  • deep vein thrombosis
  • pain
  • abdominal discomfort
  • anhedonia
  • anxiety
  • arterial thrombosis limb
  • dyspnoea
  • headache
  • hypoaesthesia
  • injury
20-29:
  • chest discomfort
  • cough
  • pain
  • rectal bleeding
  • anhedonia
  • anxiety
  • asthenia
  • biliary dyskinesia
  • cervicitis human papilloma virus
  • cholecystitis acute
30-39:
  • pneumonia
  • mucosal inflammation
  • venoocclusive disease
  • deep vein thrombosis
  • pulmonary embolism
  • renal failure
  • dyspnoea
  • ascites
  • fluid overload
  • pyrexia
40-49:
  • anaemia
  • febrile neutropenia
  • platelet count decreased
  • white blood cell count decreased
  • cardiac disorder
  • diarrhoea
  • lymphatic disorder
  • cardiac failure congestive
  • type 2 diabetes mellitus
  • obesity
50-59:
  • anxiety
  • chest pain
  • cough
  • dyspnoea
  • depression
  • gastritis
  • insomnia
  • pain
  • sinusitis
  • oedema peripheral
60+:
  • dyspnoea
  • pain
  • asthenia
  • pneumonia
  • back pain
  • general physical health deterioration
  • anaemia
  • chest pain
  • chronic obstructive pulmonary disease
  • anxiety

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Benzonatate and Mucinex?

Can you answer these questions?

More questions for: Benzonatate, Mucinex

You may be interested in these reviews

More reviews for: Benzonatate, Mucinex

On eHealthMe, Benzonatate (benzonatate) is often used to treat cough. Mucinex (guaifenesin) is often used to treat cough. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.